Immuneering Corporation

Provider of an AI-enabled bioinformatics platform for clinical solutions

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups73 employees language immuneering.com

Registered entities

Innovation

13 patent families (2 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace accelerating. Cited 576 times.

YearFilings
20121
20151
20161
20171
20212
20221
20232
20246
20254
20261

Social engagement

Social engagement: 4.2K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital343%
Other / undisclosed457%

Hiring activity

Hires occasionally

2 roles tracked across 1 of the last 12 months

27 Jan 2026 · (Associate) Director, Clinical Scientist · New York

27 Jan 2026 · Director, Clinical Project Management · Cambridge

30 Oct 2025 · Director, Quality Assurance · Cambridge

Based on job postings tracked across public sources.

Recent activity

26 Jun 2026
Event
BIO2026
22 Jun 2026
Event
Success in a Product-First Market panel at the BIO2026 International Convention
18 Jun 2026
Event
BIO2026 International Convention - Success in a Product-First Market: Balancing Lead Asset Focus and Pipeline Potential
Coming soon